Department of Pain, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China
Department of Pain, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.
BMJ Open. 2021 May 21;11(5):e043064. doi: 10.1136/bmjopen-2020-043064.
Several systematic reviews and meta-analysis indicate that acupuncture and related therapies may be a valuable adjunctive technique to pharmacological interventions for pain management of postherpetic neuralgia (PHN). However, the robustness of the results of these studies has not been evaluated. The aim of this proposed umbrella review is to provide more reliable evidence of the effectiveness of acupuncture therapy for PHN based on medical references for healthcare decision makers.
PubMed, EMBASE, The Cochrane Library, Web of Science, Chinese BioMedical Literature Database, VIP Database for Chinese Technical Periodicals, China National Knowledge Infrastructure and Wan fang Database will be used to retrieve reviews. The time of publication will be limited from inception to March 2021. Two reviewers will screen all retrieved articles independently to identify their eligibility and extract the data. The quality will be assessed independently by two trained reviewers using Assessment of Multiple Systematic Reviews-2 for methodological quality, Risk of Bias in Systematic Review for level of bias, Preferred Reporting Items for Systematic Reviews and Meta-Analysis for reporting quality and Grading of Recommendations Assessment, Development and Evaluation for the quality of evidence. Any disagreements will be settled by discussion or the involvement of a third reviewer.
The protocol of this review does not require ethical approval because the research will be based on publicly available data. The findings will be disseminated through publication in peer-reviewed international journals or presentation in academic conference.
CRD42020173341.
PRISMA-P, 2015.
几项系统评价和荟萃分析表明,针灸和相关疗法可能是治疗疱疹后神经痛(PHN)的一种有价值的辅助技术,可以与药物干预相结合。然而,这些研究结果的稳健性尚未得到评估。本拟议的伞式综述旨在根据医疗参考资料为医疗保健决策者提供更可靠的证据,证明针灸疗法治疗 PHN 的有效性。
将使用 PubMed、EMBASE、The Cochrane Library、Web of Science、中国生物医学文献数据库、维普数据库、中国国家知识基础设施和万方数据库检索综述。出版时间将从成立到 2021 年 3 月。两名评审员将独立筛选所有检索到的文章,以确定其合格性并提取数据。两名经过培训的评审员将独立评估质量,使用评估多个系统评价-2 评估方法质量、系统评价偏倚风险评估偏倚水平、系统评价和荟萃分析的首选报告项目评估报告质量以及推荐评估、发展和评价的分级评估证据质量。任何分歧将通过讨论或第三方评审员的参与来解决。
本综述的方案不需要伦理批准,因为研究将基于公开可用的数据。研究结果将通过发表在同行评议的国际期刊上或在学术会议上的演讲来传播。
PRISMA-P 登记号:CRD42020173341。
PRISMA-P,2015。